Postoperative Analgesia of Quadratus Lumborum Block Versus Epidural Block After Major Abdominal Surgeries

NCT ID: NCT04541732

Last Updated: 2020-09-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-01

Study Completion Date

2019-05-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acute postoperative pain is an important issue after major abdominal surgeries for which different analgesic modalities have been tried.

Epidural analgesia is the recommended technique to relieve pain after major abdominal surgeries owing to the proved superior analgesia, reduction of opioid-related side effects as nausea, vomiting, pruritis and sedation, earlier recovery of bowel function and earlier ability for postoperative mobility. However, it is not without complications.

Quadratus lumborum block is an ultrasound-guided block that provides patients with both visceral and somatic blockade. It lessens the potential risks associated with neuraxial techniques, so it may represent a novel alternative approach for analgesia after major abdominal surgeries.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to detect the feasibility of ultra-sound guided bilateral quadratus lumborum block as a postoperative analgesic modality after major abdominal surgery in comparison to epidural block and its effects on total rescue analgesic requirements in the 1st postoperative 24hours, time to first analgesic request, pain VAS scores, intraoperative and postoperative hemodynamics and postoperative opioid-related side effects.

Under complete aseptic conditions, the patients will receive either thoracic epidural block or bilateral ultrasound-guided quadratus lumborum block after induction of general anaesthesia

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Elective Major Abdominal Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Single blind study
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants
Single blind study

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Thoracic epidural block

Patients will receive thoracic epidural block following induction of general anaesthesia

Group Type EXPERIMENTAL

Thoracic epidural block

Intervention Type OTHER

Patients who will be subjected to epidural block will be placed in the lateral position then, after sterilization of the skin, 21 G spinal needle will be inserted at T9-T11 intervertebral spaces. The epidural space will be located using the loss of resistance to air technique and a mixture of bupivacaine 0.25% + 50 μ fentanyl targeting T6 level will be injected following induction of general anaesthesia.

Induction of general anaesthesia with propofol

Intervention Type DRUG

propofol: 1.5-2.5mg/Kg

Muscle Relaxant

Intervention Type DRUG

Atracurium : 0.5mg/Kg.

Maintenance of general anaesthesia

Intervention Type DRUG

Sevoflurane 0.7-1.5 MAC in 40% oxygen

Bilateral quadratus lumborum block

Patients will receive Ultrasound-guided bilateral quadratus lumborum block following induction of general anaesthesia

Group Type ACTIVE_COMPARATOR

Ultrasound-guided bilateral quadratus lumborum block

Intervention Type OTHER

Patients who will be subjected to major abdominal surgeries will be placed in a supine position with a pillow under their side to obtain an appropriate view of quadratus lumborum muscle. After sterilization of the skin and ultrasound-guided identification of the quadratus lumborum muscle, 20 ml bupivacaine 0.25% + 25μ fentanyl will be injected on each side following induction of general anaesthesia

Induction of general anaesthesia with propofol

Intervention Type DRUG

propofol: 1.5-2.5mg/Kg

Muscle Relaxant

Intervention Type DRUG

Atracurium : 0.5mg/Kg.

Maintenance of general anaesthesia

Intervention Type DRUG

Sevoflurane 0.7-1.5 MAC in 40% oxygen

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thoracic epidural block

Patients who will be subjected to epidural block will be placed in the lateral position then, after sterilization of the skin, 21 G spinal needle will be inserted at T9-T11 intervertebral spaces. The epidural space will be located using the loss of resistance to air technique and a mixture of bupivacaine 0.25% + 50 μ fentanyl targeting T6 level will be injected following induction of general anaesthesia.

Intervention Type OTHER

Ultrasound-guided bilateral quadratus lumborum block

Patients who will be subjected to major abdominal surgeries will be placed in a supine position with a pillow under their side to obtain an appropriate view of quadratus lumborum muscle. After sterilization of the skin and ultrasound-guided identification of the quadratus lumborum muscle, 20 ml bupivacaine 0.25% + 25μ fentanyl will be injected on each side following induction of general anaesthesia

Intervention Type OTHER

Induction of general anaesthesia with propofol

propofol: 1.5-2.5mg/Kg

Intervention Type DRUG

Muscle Relaxant

Atracurium : 0.5mg/Kg.

Intervention Type DRUG

Maintenance of general anaesthesia

Sevoflurane 0.7-1.5 MAC in 40% oxygen

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* American Society of Anesthesiologists (ASA) physical status I-III

Exclusion Criteria

* Patient's refusal
* Significant cardiac, disease.
* Significant hepatic disease.
* Significant renal disease (serum creatinine ˃ 1.5 mg/dl).
* Patients with drug abuse
* Allergy to study medications
* Mental disease
* Communication barrier.
* Coagulopathy.
* Local skin infection
Minimum Eligible Age

20 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mansoura University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohammed A Ghanem, MD

Role: STUDY_DIRECTOR

Associate Professor

Mona A Hasheesh, MD

Role: STUDY_CHAIR

Professor

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mohammed A Ghanem

Al Mansurah, DK, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MS ∕18.06.187

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.